Crystal forms of (R) - N-methylnaltrexone bromide and uses thereof
Details for Australian Patent Application No. 2008233133 (hide)
International Classifications
Event Publications
22 October 2009 PCT application entered the National Phase
PCT publication WO2008/121352 Priority application(s): WO2008/121352
19 November 2009 Amendment Made
The nature of the amendment is: Amend applicant name to include co-applicant Wyeth
5 August 2010 Alteration of Name
The name of the applicant has been altered to Progenics Pharmaceuticals, Inc.; Wyeth LLC
4 November 2010 Amendment Made
The nature of the amendment is: Amend co-inventor name from Ali, Kadum A. to Al Shareffi, Kadum A.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008233139-System for color match and digital color display
2008233129-Peripheral opioid receptor antagonists and uses thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser